A randomized, double-blind pilot study vs placebo for the evaluation of the therapeutic effect of erythropoietin administered by iv route in patients whith diabetic neuropathy.

INTERVENTION: Pharmaceutical Form: Solution for injection CAS Number: 113427‐24‐0 Current Sponsor code: Epo Concentration unit: IU international unit(s) Concentration type: equal Concentration number: 40000‐ CONDITION: Diabetic neuropathy ; MedDRA version: 6.1 Level: PT Classification code 10012680 PRIMARY OUTCOME: Main Objective: Primary end point(s): Secondary Objective: INCLUSION CRITERIA: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range